The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-nitrobenzyl)-5-(2-oxo-2H-chromen-6-yl)-1H-pyrrole-2-carbonitrile ID: ALA3975442
PubChem CID: 134152665
Max Phase: Preclinical
Molecular Formula: C21H13N3O4
Molecular Weight: 371.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccc(-c2ccc3oc(=O)ccc3c2)n1Cc1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C21H13N3O4/c22-12-18-7-8-19(15-3-9-20-16(11-15)4-10-21(25)28-20)23(18)13-14-1-5-17(6-2-14)24(26)27/h1-11H,13H2
Standard InChI Key: YWFKGEUMVYHGIM-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
9.4045 -18.2382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4034 -19.0577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1114 -19.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1096 -17.8293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8183 -18.2346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8217 -19.0598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5340 -19.4672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2476 -19.0539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2442 -18.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5273 -17.8168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9564 -19.4606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7012 -17.8301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6154 -17.0178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8162 -16.8477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4077 -17.5555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9548 -18.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4873 -16.1007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1548 -15.3542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3221 -16.6075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3202 -15.7903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0265 -15.3846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0250 -14.5682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3158 -14.1604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6067 -14.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6117 -15.3901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3133 -13.3384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6041 -12.9324 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0195 -12.9272 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 2 0
1 12 1 0
17 18 3 0
14 17 1 0
13 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
26 27 2 0
26 28 1 0
23 26 1 0
M CHG 2 26 1 28 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 371.35Molecular Weight (Monoisotopic): 371.0906AlogP: 4.09#Rotatable Bonds: 4Polar Surface Area: 102.07Molecular Species: ┄HBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.09CX LogD: 4.09Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.31Np Likeness Score: -0.86
References 1. Kinoshita M, Negishi M, Sakai H, Hirano T, Mori S, Fujii S, Kagechika H, Tanatani A.. (2016) Development of 6-arylcoumarins as nonsteroidal progesterone antagonists. Structure-activity relationships and fluorescence properties., 24 (21): [PMID:27665178 ] [10.1016/j.bmc.2016.09.020 ]